Compare $AURA vs $CLYM | Chartloom

Compare

$AURA vs $CLYM

Aura Biosciences Inc · Climb Bio Inc

AURA

Aura Biosciences Inc

CLYM

Climb Bio Inc

Compare $AURA vs $CLYM

Comparing Aura Biosciences Inc and Climb Bio Inc

AURAAura Biosciences Inc

CLYMClimb Bio Inc

AURAAura Biosciences Inc

Market cap

$676M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

23.4%

52W performance

7.4%

FCF yield

-15.3%

CLYMClimb Bio Inc

Market cap

$630M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

193.3%

52W performance

511.1%

FCF yield

-8.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AURA

CLYM

Detailed metrics comparison

AURA

Aura Biosciences Inc

CLYM

Climb Bio Inc

Market Cap

AURA$676M

CLYM$630M

Enterprise Value

AURA$609M

CLYM$586M

Price

AURA$6.54

CLYM$11.00

P/E Ratio

AURAN/A

CLYMN/A

P/S Ratio

AURA0.00x

CLYM0.00x

EV/Sales

AURA0.00x

CLYM0.00x

EV/EBITDA

AURA0.00x

CLYM0.00x

P/B Ratio

AURA2.00x

CLYM2.62x

P/FCF Ratio

AURAN/A

CLYMN/A

EV/FCF

AURA-5.89x

CLYM-11.04x

PEG Ratio

AURAN/A

CLYMN/A

Forward P/E (NTM)

AURAN/A

CLYMN/A

Forward P/S (NTM)

AURAN/A

CLYMN/A

Revenue (TTM)

AURA$0

CLYM$0

Revenue Growth (YoY)

AURAN/A

CLYMN/A

Forward Rev Growth

AURA591.6%

CLYM27.3%

Gross Margin (TTM)

AURA0.0%

CLYM0.0%

Operating Margin (TTM)

AURA0.0%

CLYM0.0%

EBITDA Margin (TTM)

AURA0.0%

CLYM0.0%

Net Margin (TTM)

AURA0.0%

CLYM0.0%

FCF Margin (TTM)

AURAN/A

CLYMN/A

Net Income (TTM)

AURA$-131M

CLYM$-58M

FCF (TTM)

AURA$-103M

CLYM$-53M

EPS (TTM)

AURA-$1.38

CLYM-$0.76

ROE (TTM)

AURA-7318.0%

CLYM-3179.0%

ROA (TTM)

AURA-6200.0%

CLYM-3079.0%

ROIC (TTM)

AURA-7318.0%

CLYM-3179.0%

Cash

AURA$68M

CLYM$44M

Debt

AURA$0

CLYM$0

Net Cash/Debt

AURA$68M

CLYM$44M

Current Ratio (TTM)

AURA16.82x

CLYM31.45x

Quick Ratio (TTM)

AURA16.69x

CLYM30.86x

Debt/Equity (TTM)

AURA0.00x

CLYM0.00x

Debt/Assets (TTM)

AURA0.0%

CLYM0.0%

Interest Coverage (TTM)

AURAN/A

CLYMN/A

Net Debt/EBITDA (TTM)

AURA0.00x

CLYM0.00x

Beta

AURA0.45

CLYM-0.01

52W Performance

AURA7.4%

CLYM511.1%

YTD Performance

AURA23.4%

CLYM193.3%

% from 52W High

AURA-31.4%

CLYM-40.0%

% from 52W Low

AURA38.3%

CLYM572.8%

Asset Turnover (TTM)

AURA0.00x

CLYM0.00x

FCF Yield (TTM)

AURA-15.3%

CLYM-8.4%

Earnings Yield (TTM)

AURA-19.4%

CLYM-9.1%

Dividend Yield (TTM)

AURAN/A

CLYMN/A

Rule of 40

AURA0.0

CLYM0.0

EV/GP/RG

AURAN/A

CLYMN/A

Ticker research

View AURA research View CLYM research

Metric	AURA Aura Biosciences Inc	CLYM Climb Bio Inc
Market & Valuation
Market Cap	$676M	$630M
Enterprise Value	$609M	$586M
Price	$6.54	$11.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.00x	2.62x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.89x	-11.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	591.6%	27.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-131M	$-58M
FCF (TTM)	$-103M	$-53M
EPS (TTM)	-$1.38	-$0.76
ROE (TTM)	-7318.0%	-3179.0%
ROA (TTM)	-6200.0%	-3079.0%
ROIC (TTM)	-7318.0%	-3179.0%
Financial Health
Cash	$68M	$44M
Debt	$0	$0
Net Cash/Debt	$68M	$44M
Current Ratio (TTM)	16.82x	31.45x
Quick Ratio (TTM)	16.69x	30.86x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.45	-0.01
52W Performance	7.4%	511.1%
YTD Performance	23.4%	193.3%
% from 52W High	-31.4%	-40.0%
% from 52W Low	38.3%	572.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.3%	-8.4%
Earnings Yield (TTM)	-19.4%	-9.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AURA research	View CLYM research

Valuation

P/S Ratio

AURA

0.00x

CLYM

0.00x

EV/FCF

CLYM

-11.04x

AURA

-5.89x

Growth & revenue

Forward Revenue Growth

AURA

591.6%

CLYM

27.3%

Profitability & performance

Gross Margin

AURA

0.0%

CLYM

0.0%

ROE

CLYM

-3179.0%

AURA

-7318.0%

FCF Yield %

CLYM

-8.4%

AURA

-15.3%

52-Week Performance

CLYM

511.1%

AURA

7.4%

Detailed metrics comparison

AURA

Aura Biosciences Inc

CLYM

Climb Bio Inc

Market Cap

AURA$676M

CLYM$630M

Enterprise Value

AURA$609M

CLYM$586M

Price

AURA$6.54

CLYM$11.00

P/E Ratio

AURAN/A

CLYMN/A

P/S Ratio

AURA0.00x

CLYM0.00x

EV/Sales

AURA0.00x

CLYM0.00x

EV/EBITDA

AURA0.00x

CLYM0.00x

P/B Ratio

AURA2.00x

CLYM2.62x

P/FCF Ratio

AURAN/A

CLYMN/A

EV/FCF

AURA-5.89x

CLYM-11.04x

PEG Ratio

AURAN/A

CLYMN/A

Forward P/E (NTM)

AURAN/A

CLYMN/A

Forward P/S (NTM)

AURAN/A

CLYMN/A

Revenue (TTM)

AURA$0

CLYM$0

Revenue Growth (YoY)

AURAN/A

CLYMN/A

Forward Rev Growth

AURA591.6%

CLYM27.3%

Gross Margin (TTM)

AURA0.0%

CLYM0.0%

Operating Margin (TTM)

AURA0.0%

CLYM0.0%

EBITDA Margin (TTM)

AURA0.0%

CLYM0.0%

Net Margin (TTM)

AURA0.0%

CLYM0.0%

FCF Margin (TTM)

AURAN/A

CLYMN/A

Net Income (TTM)

AURA$-131M

CLYM$-58M

FCF (TTM)

AURA$-103M

CLYM$-53M

EPS (TTM)

AURA-$1.38

CLYM-$0.76

ROE (TTM)

AURA-7318.0%

CLYM-3179.0%

ROA (TTM)

AURA-6200.0%

CLYM-3079.0%

ROIC (TTM)

AURA-7318.0%

CLYM-3179.0%

Cash

AURA$68M

CLYM$44M

Debt

AURA$0

CLYM$0

Net Cash/Debt

AURA$68M

CLYM$44M

Current Ratio (TTM)

AURA16.82x

CLYM31.45x

Quick Ratio (TTM)

AURA16.69x

CLYM30.86x

Debt/Equity (TTM)

AURA0.00x

CLYM0.00x

Debt/Assets (TTM)

AURA0.0%

CLYM0.0%

Interest Coverage (TTM)

AURAN/A

CLYMN/A

Net Debt/EBITDA (TTM)

AURA0.00x

CLYM0.00x

Beta

AURA0.45

CLYM-0.01

52W Performance

AURA7.4%

CLYM511.1%

YTD Performance

AURA23.4%

CLYM193.3%

% from 52W High

AURA-31.4%

CLYM-40.0%

% from 52W Low

AURA38.3%

CLYM572.8%

Asset Turnover (TTM)

AURA0.00x

CLYM0.00x

FCF Yield (TTM)

AURA-15.3%

CLYM-8.4%

Earnings Yield (TTM)

AURA-19.4%

CLYM-9.1%

Dividend Yield (TTM)

AURAN/A

CLYMN/A

Rule of 40

AURA0.0

CLYM0.0

EV/GP/RG

AURAN/A

CLYMN/A

Ticker research

View AURA research View CLYM research

Metric	AURA Aura Biosciences Inc	CLYM Climb Bio Inc
Market & Valuation
Market Cap	$676M	$630M
Enterprise Value	$609M	$586M
Price	$6.54	$11.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.00x	2.62x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.89x	-11.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	591.6%	27.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-131M	$-58M
FCF (TTM)	$-103M	$-53M
EPS (TTM)	-$1.38	-$0.76
ROE (TTM)	-7318.0%	-3179.0%
ROA (TTM)	-6200.0%	-3079.0%
ROIC (TTM)	-7318.0%	-3179.0%
Financial Health
Cash	$68M	$44M
Debt	$0	$0
Net Cash/Debt	$68M	$44M
Current Ratio (TTM)	16.82x	31.45x
Quick Ratio (TTM)	16.69x	30.86x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.45	-0.01
52W Performance	7.4%	511.1%
YTD Performance	23.4%	193.3%
% from 52W High	-31.4%	-40.0%
% from 52W Low	38.3%	572.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.3%	-8.4%
Earnings Yield (TTM)	-19.4%	-9.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AURA research	View CLYM research